Oliveira Steven Michael

13D and 13G Filings

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Forte Biosciences, Inc. 13G/A Amendment 1 FBRX · 34962G208	FBRX	34962G208	2.4%	300,100	13G/A Amendment 1	1/9/2026 Event 1/8/2026
Oliveira Steven Michael			2.4%	300,100
Nemean Asset Management, LLC			2.4%	300,100
Athira Pharma, Inc. 13G/A Amendment 1 ATHA · 04746L104	ATHA	04746L104	4.1%	161,218	13G/A Amendment 1	10/10/2025 Event 10/1/2025
Oliveira Steven Michael			4.1%	161,218
Nemean Asset Management, LLC			3.8%	151,218
South Ocean Capital LLC			0.3%	10,000
South Ocean Capital Management LLC			0%	0
Athira Pharma, Inc. 13G ATHA · 04746L104	ATHA	04746L104	5.1%	1,994,649	13G	4/16/2025 Event 4/14/2025
Steven Michael Oliveira			5.1%	1,994,649
Nemean Asset Management, LLC			4.2%	1,644,649
South Ocean Capital Management LLC			<0.1%	250,000
South Ocean Capital LLC			<0.1%	100,000
Forte Biosciences, Inc. 13G FBRX · 34962G208	FBRX	34962G208	6.8%	432,276	13G	1/10/2025 Event 11/20/2024
Nemean Asset Management, LLC			6.8%	432,276
Steven M. Oliveira			6.8%	432,276

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.